Last updated on April 2016

TREg Activation in the Treatment of the PELADE (Alopecia Areata)

Brief description of study

In a prospective pilot study the investigators showed that low doses of IL2 could be beneficial for severe AA inducing a long lasting regrowth in 4 out of the 5 patients treated. The objective of this study is to compare the long term efficacy of low doses of IL2 versus placebo in a multicenter prospective randomized double blind study.

Clinical Study Identifier: NCT02557074

Contact Investigators or Research Sites near you

Start Over

Richard Marie-Aleth, PUPH

AP-HM - La timone - Dermatologie
Marseille, France
  Connect »

Reygagne Pierre, Ph

AP-HP St Louis - Dermatologie
Paris, France
  Connect »

Meunier Laurent, PUPH

CHU de Nimes - Dermatologie
Nîmes, France
  Connect »

Hubiche Thomas, Ph

CHI St Raphael Fr jus - Dermatologie
Fréjus, France
  Connect »

Dereure Olivier, PUPH

CHU Montpellier - Dermatologie
Montpellier, France
  Connect »

Le Duff Florence, PH

CHU de Nice - dermatologie
Nice, France
  Connect »